Market research store

Global Cancer Diagnostics Market to Progress at 4.70% CAGR from 2014 to 2023

Zion Research has published a new report titled “Cancer Diagnostics Market by Methods (Tumor Biomarker Tests, Imaging, Endoscopy, Biopsy) for Blood Cancer, Breast Cancer, Colorectal Cancer (CRC), Lung Cancer, Others: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 – 2020” According to the report, global demand for cancer diagnostics was valued at USD 80.67 billion in 2014, and is expected to reach USD 128.6 billion in 2020, growing at a CAGR of 7.6% between 2015 and 2020.

Browse request sample report@

Cancer is also called as malignancy in which abnormal growth of cells form group diseases. Not all the cancer has potential of spreading to other parts of the body, there are two types of tumors, cancerous or malignant (spreads throughout the body) and benign tumors or static tumors which do not spread to other body parts. Prolonged cough, new lump, weight loss and abnormal bleeding are the commonly occurring symptoms in cancer. Cancer diagnostic deals with the management of cancer by providing a wide range of high-value tools for screening, diagnosis and monitoring of different cancer types. It is used to detect the cancer and also performs different treatments.

On the basis of method, the global cancer diagnostics market is divided into tumor biomarker tests, endoscopy, imaging, and biopsy. The cancer imaging method is the fastest growing segment of cancer diagnosis market. The imaging sector dominated the global cancer diagnostics with significant market share of the total market in 2014.

Some of the key player for global cancer diagnostics market includes Abbott Laboratories, Inc., Ambry Genetics, AstraZeneca plc, bioMeriux SA, Eli Lilly and Company, Genoptix, Inc., GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., and Pfizer, Inc.

This report segments the global cancer diagnostics market as follows:

Global Cancer Diagnostics Market: Methods Segment Analysis

  • Tumor Biomarker Tests
  • Imaging
  • Endoscopy
  • Biopsy

Global Cancer Diagnostics Market: Application Segment Analysis

  • Blood Cancer
  • Breast Cancer
  • Colorectal Cancer (CRC)
  • Lung Cancer
  • Others

Global Cancer Diagnostics Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • Germany
    • France
    • UK
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Contact US:

Joel John
3422 SW 15 Street,Suit #8138
Deerfield Beach,Florida 33442
United States
Toll Free: +1-855-465-4651 (USA-CANADA)
Tel: +1-386-310-3803

Market research store

Boston, MA,
United States


Powered by